December 10, 2013. Agreement to supply reagents for next generation sequencing

Cytognomix has agreed to provide hybridization enrichment products to the Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine at the Istituto Nazionale dei Tumori (INT), Fondazione IRCCS-Milan for sequencing of genes associated inherited neoplastic disease. The company’s scProbe design technology was selected by the INT because it provides the highest depth and breadth of sequence coverage for sequencing of complete cancer genes on the market today.


Posted in News.